acquired
Stage
1
Investors
About
ImmPACT Bio develops next-generation CAR T-cell therapies focusing on innovative immunotherapy treatments for cancer.
Explore ImmPACT Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.